MARKET

OMER

OMER

Omeros
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.99
+0.92
+5.39%
Pre Market: 18.25 +0.26 +1.45% 09:22 01/15 EST
OPEN
17.10
PREV CLOSE
17.07
HIGH
18.18
LOW
17.10
VOLUME
2.07K
TURNOVER
--
52 WEEK HIGH
25.46
52 WEEK LOW
8.50
MARKET CAP
1.11B
P/E (TTM)
-7.5487
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Omeros to Present at the 39th Annual J.P. Morgan Healthcare Conference
Omeros Corporation (Nasdaq: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference this week. This conference is being held as a virtual conference this year. The presentation is scheduled for Wednesday, January 13, 2021 at 10:50 a.m. EST.
BusinessWire · 3d ago
BofA's biopharma picks into 2021 set to build with new launches, 'beatable' expectations
A substantive review of its U.S. biopharmaceutical coverage finds BofA looking to a "return to normal" for the sector in a year expected to be dominated by news about a
Seekingalpha · 01/05 23:37
Is OMER A Good Stock To Buy Now?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund fili...
Insider Monkey · 12/16/2020 04:42
Analysts Just Published A Bright New Outlook For Omeros Corporation's (NASDAQ:OMER)
Celebrations may be in order for Omeros Corporation ( NASDAQ:OMER ) shareholders, with the analysts delivering a...
Simply Wall St. · 12/05/2020 07:43
Analysts Just Published A Bright New Outlook For Omeros Corporation's (NASDAQ:OMER)
Celebrations may be in order for Omeros Corporation ( NASDAQ:OMER ) shareholders, with the analysts delivering a...
Simply Wall St. · 12/05/2020 07:43
Enlivex Therapeutics, Cellectar Biosciences leads healthcare gainers; ReWalk Robotics, Precision BioSciences among major losers
Gainers: Enlivex Therapeutics (ENLV) +24%, Cellectar Biosciences (CLRB) +18%, Omeros (OMER) +15%, Trxade Group (MEDS) +13%, AlloVir (ALVR) +10%.Losers: ReWalk Robotics (RWLK) -11%, Precision BioSciences (DTIL) -11%, Merrimack Pharmaceuticals (MACK) -10%, NanoVibronix (NAOV) -10%, Codexis CDXS -9%.
Seekingalpha · 12/03/2020 16:10
Thinking about buying stock in Pfizer, China Automotive Systems, Omeros Corp, Nio, or FuelCell Energy?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, CAAS, OMER, NIO, and FCEL.
PR Newswire - PRF · 12/03/2020 13:30
Thinking about buying stock in Pfizer, China Automotive Systems, Omeros Corp, Nio, or FuelCell Energy?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, CAAS, OMER, NIO, and FCEL.
PR Newswire - PRF · 12/03/2020 13:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OMER. Analyze the recent business situations of Omeros through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OMER stock price target is 33.17 with a high estimate of 75.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 194
Institutional Holdings: 36.81M
% Owned: 59.71%
Shares Outstanding: 61.65M
TypeInstitutionsShares
Increased
58
5.78M
New
48
1.76M
Decreased
24
4.43M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.30%
Pharmaceuticals & Medical Research
+1.47%
Key Executives
Chairman/President/Chief Executive Officer/Director
Gregory Demopulos
Chief Accounting Officer/Vice President - Finance/Treasurer
Michael Jacobsen
Chief Scientific Officer/Vice President
George Gaitanaris
Vice President/General Counsel/Secretary
Peter Cancelmo
Vice President
Christopher Bral
Vice President
Daniel Kirby
Vice President
Alexander Gragerov
Vice President
Bruce Meiklejohn
Vice President
Catherine Melfi
Vice President
Tina Quinton
Vice President
J. Steven Whitaker
Vice President - Business Development
Timothy Duffy
Lead Director/Independent Director
Thomas Cable
Director
Peter Demopulos
Independent Director
Ray Aspiri
Independent Director
Thomas Bumol
Independent Director
Arnold Hanish
Independent Director
Leroy Hood
Independent Director
Rajiv Shah
Independent Director
Kurt Zumwalt
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About OMER
Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The Company’s drug product OMIDRIA (phenylephrine and ketorolac intraocular solution) is used during cataract surgery or intraocular lens (IOL) replacement. The Company’s clinical-stage development programs are focused on complement-associated thrombotic microangiopathies, complement-mediated glomerulonephropathies, Huntington’s disease and cognitive impairment, and addictive and compulsive disorders. It also offers a diverse group of preclinical programs and platforms that are used to unlock new G protein-coupled receptor (GPCR) drug targets and to generate antibodies.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Omeros Corporation stock information, including NASDAQ:OMER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMER stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OMER stock methods without spending real money on the virtual paper trading platform.